PCV9 CARDIOVASCULAR EVENT REDUCTION AFTER TREATMENT WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS GENERIC SIMVASTATIN THERAPY FROM A MANAGED CARE ORGANIZATIONS PERSPECTIVE IN THE UNITED STATES
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74536-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74536-8/fulltext
Title :
PCV9 CARDIOVASCULAR EVENT REDUCTION AFTER TREATMENT WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS GENERIC SIMVASTATIN THERAPY FROM A MANAGED CARE ORGANIZATIONS PERSPECTIVE IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74536-8&doi=10.1016/S1098-3015(10)74536-8
First page :
Section Title :
Open access? :
No
Section Order :
464